EANS-Adhoc: WORLD OF MEDICINE investing more in research & development and sales expansion/ Adjustment to 2009 earnings goal/ Management Board plans to continue share buy-back/

--------------------------------------------------------------------------------
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
adhoc with the aim of a Europe-wide distribution. The issuer is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------

Share buy-back

27.05.2009

Medical device manufacturer WORLD OF MEDICINE is stepping up
investments in research and development as well as in the expansion
of its sales. The objective is to expand the Company's market
position and secure its employee's jobs over the medium to long-term,
instead of focusing on short term yield targets. For this reason, the
Management Board today announced that it is approving the necessary
expenditures and adjusting the earnings goal for fiscal year 2009 to
a return on sales before taxes of 6%. Originally, 11% was planned.
The current sales and cost projection until the end of fiscal year
2009 is the basis for this change.

Moreover, the Management Board with approval of the Supervisory
Board, today decided to continue with immediate effect the buy-back
of own shares carried out under the management of a bank until
November 27, 2010 in case of a renewal of the authorization to
buy-back own shares of the General Shareholders' Meeting of W.O.M.
WORLD OF MEDICINE AG taking place tomorrow.The average purchase price
of the shares may not be more than 10 % above or more than 10 % below
the average Xetra Closing Price (or if this authorization is based on
the Xetra closing price the closing price determined by a system
which may have replaced the Xetra System) at the Frankfurt Exchange
in the 5 days preceding the trade.

The Management Board of W.O.M. WORLD OF MEDICINE AG with approval of
the Supervisory Board had decided on May 4, 2009 to buy-back own
shares on the basis of the authorization of the General Shareholders'
Meeting of W.O.M. WORLD OF MEDICINE AG on May 29, 2008. According to
the resolution of the Management Board the buyback was limited until
May 27, 2009. An independent bank purchased a total of 2,370 shares
from May 19 to May 26, 2009 in the total amount of EUR 22,240
(without additional charges). This corresponds to 0.3 % of the share
capital. The average price per share reached EUR9.38. The purchase of
the shares was conducted by an independent bank at the electronic
trading platform of the Frankfurt stock exchange (Xetra). The Company
holds own shares equal to 2.94 % of the share capital at the time of
the General Shareholders Meeting of May 28, 2009 (EUR9,000,000). In
case the buy-back is to be continued the Company, according to legal
provisions, may buy-back up to 7.06 % of this share capital. An
overview of all transactions of the share buyback is available at
www.world- of-medicine.com under 'Investor Relations'.

The Management Board

end of announcement euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: W.O.M. WORLD OF MEDICINE AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Stefanie Gehrke

Cell Phone: + 49 (0) 172 402 67 40

E-Mail: stefanie.gehrke@womcorp.com

Branche: Pharmaceuticals
ISIN: DE0006637390
WKN: 663739
Index: CDAX, Prime All Share, Technologie All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Stuttgart / free trade
Düsseldorf / free trade
München / free trade